Add to ORKG<p>Supplemental material for A Bayesian model to estimate the cutoff and the clinical utility of a biomarker assay by Eleni Vradi, Thomas Jaki, Richardus Vonk and Werner Brannath in Statistical Methods in Medical Research</p
Supplemental Material for Bayesian Phase II optimization for time-to-event data based on historical ...
<p>Supplemental Material for Robustness of testing procedures for confirmatory subpopulation analyse...
Supplemental material, DS_10.1177_0272989X18788537 for Bayesian Multiparameter Evidence Synthesis to...
Supplemental Material for A Bayesian method to estimate the optimal threshold of a marker used to se...
<p>Supplemental material for Bayesian sample size re-estimation using power priors by TB Brakenhoff,...
Supplemental material, Supplemental Material1 for Bayesian treatment comparison using parametric mix...
Supplemental material, Supplemental Material2 for Bayesian treatment comparison using parametric mix...
To enable targeted therapies and enhance medical decision-making, biomarkers are increasingly used a...
<p>Supplemental material for Estimating mean local posterior predictive benefit for biomarker-guided...
Supplemental material, Supplemental material3 for Accurate quantification of uncertainty in epidemic...
Supplemental Material for Bayesian sensitivity analysis for unmeasured confounding in causal mediati...
Supplemental material, Supplemental material1 for Accurate quantification of uncertainty in epidemic...
<p>Supplemental material for Bayesian semiparametric modeling for HIV longitudinal data with censori...
Supplemental material, Supplemental material2 for Accurate quantification of uncertainty in epidemic...
Supplementary Material for Bootstrap-based testing approaches for the assessment of the diagnostic a...
Supplemental Material for Bayesian Phase II optimization for time-to-event data based on historical ...
<p>Supplemental Material for Robustness of testing procedures for confirmatory subpopulation analyse...
Supplemental material, DS_10.1177_0272989X18788537 for Bayesian Multiparameter Evidence Synthesis to...
Supplemental Material for A Bayesian method to estimate the optimal threshold of a marker used to se...
<p>Supplemental material for Bayesian sample size re-estimation using power priors by TB Brakenhoff,...
Supplemental material, Supplemental Material1 for Bayesian treatment comparison using parametric mix...
Supplemental material, Supplemental Material2 for Bayesian treatment comparison using parametric mix...
To enable targeted therapies and enhance medical decision-making, biomarkers are increasingly used a...
<p>Supplemental material for Estimating mean local posterior predictive benefit for biomarker-guided...
Supplemental material, Supplemental material3 for Accurate quantification of uncertainty in epidemic...
Supplemental Material for Bayesian sensitivity analysis for unmeasured confounding in causal mediati...
Supplemental material, Supplemental material1 for Accurate quantification of uncertainty in epidemic...
<p>Supplemental material for Bayesian semiparametric modeling for HIV longitudinal data with censori...
Supplemental material, Supplemental material2 for Accurate quantification of uncertainty in epidemic...
Supplementary Material for Bootstrap-based testing approaches for the assessment of the diagnostic a...
Supplemental Material for Bayesian Phase II optimization for time-to-event data based on historical ...
<p>Supplemental Material for Robustness of testing procedures for confirmatory subpopulation analyse...
Supplemental material, DS_10.1177_0272989X18788537 for Bayesian Multiparameter Evidence Synthesis to...